Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease
Open Access
- 1 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 203 (7) , 893-905
Abstract
Rationale: Health outcomes of people with coronavirus disease (COVID-19) range from no symptoms to severe illness and death. Asthma, a common chronic lung disease, has been considered likely to increase the severity of COVID-19, although data addressing this hypothesis have been scarce until very recently. Objectives: To review the epidemiologic literature related to asthma’s potential role in COVID-19 severity. Methods: Studies were identified through the PubMed (MEDLINE) and medRxiv (preprint) databases using the search terms “asthma,” “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2), and “COVID-19,” and by cross-referencing citations in identified studies that were available in print or online before December 22, 2020. Measurements and Main Results: Asthma prevalence data were obtained from studies of people with COVID-19 and regional health statistics. We identified 150 studies worldwide that allowed us to compare the prevalence of asthma in patients with COVID-19 by region, disease severity, and mortality. The results of our analyses do not provide clear evidence of increased risk of COVID-19 diagnosis, hospitalization, severity, or mortality due to asthma. Conclusions: These findings could provide some reassurance to people with asthma regarding its potential to increase their risk of severe morbidity from COVID-19.Keywords
This publication has 130 references indexed in Scilit:
- Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysisTravel Medicine and Infectious Disease, 2020
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington StateJAMA, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Prevalence, risk factors, and management of asthma in China: a national cross-sectional studyThe Lancet, 2019
- The state of the art in peer reviewFEMS Microbiology Letters, 2018
- Chronic obstructive pulmonary disease in China: a nationwide prevalence studyThe Lancet Respiratory Medicine, 2018
- National and regional asthma programmes in EuropeEuropean Respiratory Review, 2015
- Healthcare use and prescription patterns associated with adult asthma in Korea: analysis of the NHI claims databaseAllergy, 2013
- Role of viral respiratory infections in asthma and asthma exacerbationsThe Lancet, 2010